Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer

  1. Lamas, M.J.
  2. Duran, G.
  3. Balboa, E.
  4. Bernardez, B.
  5. Touris, M.
  6. Vidal, Y.
  7. Gallardo, E.
  8. Lopez, R.
  9. Carracedo, A.
  10. Barros, F.
Journal:
Pharmacogenomics

ISSN: 1462-2416 1744-8042

Year of publication: 2011

Volume: 12

Issue: 3

Pages: 433-442

Type: Article

DOI: 10.2217/PGS.10.196 GOOGLE SCHOLAR